The Journal of Urology
Volume 182, Issue 4 , Pages 1287-1293 , October 2009

Tumor Size is a Determinant of the Rate of Stage T1 Renal Cell Cancer Synchronous Metastasis

  • Giovanni Lughezzani

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    • Department of Urology, Vita-Salute San Raffaele University, Milan, Italy
  • ,
  • Claudio Jeldres

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • ,
  • Hendrik Isbarn

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    • Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • ,
  • Paul Perrotte

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Shahrokh F. Shariat

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • ,
  • Maxine Sun

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • ,
  • Hugues Widmer

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Philippe Arjane

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Francois Peloquin

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Daniel Pharand

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Jean-Jacques Patard

      Affiliations

    • Department of Urology, Rennes University Hospital, Rennes, France
  • ,
  • Markus Graefen

      Affiliations

    • Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • ,
  • Francesco Montorsi

      Affiliations

    • Department of Urology, Vita-Salute San Raffaele University, Milan, Italy
  • ,
  • Pierre I. Karakiewicz

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    • Corresponding Author InformationCorrespondence: Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montréal, Québec, Canada, H2X 3J4 (telephone: 514-890-8000-35336; FAX: 514-412-7363)

Received 26 January 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 Supported by the University of Montreal Urology Associates, Fonds de la Recherche en Santé du Québec, University of Montreal Department of Surgery and University of Montreal Foundation (PIK).

 For another article on a related topic see page 1594.

PII: S0022-5347(09)01487-6

doi: 10.1016/j.juro.2009.06.018

The Journal of Urology
Volume 182, Issue 4 , Pages 1287-1293 , October 2009